TC

22/08/2019 14:55

HEC Pharm (01558) interim net up 53% to RMB968.42m

[ET Net News Agency, 22 August 2019] YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
(01558) said its profit and total comprehensive income attributable to equity shareholders
of the company was RMB968.42 million for the six months ended 30 June 2019, a year-on-year
increase of 52.62%. The earnings per share were RMB2.15. An interim dividend of RMB1 will
be distributed.
The revenue was RMB3.07 billion, a year-on-year increase of 107.18%. The gross profit
was RMB2.62 billion, a year-on-year increase of 110.77%. (RC)

etnet財經‧生活App   財智‧健康‧品味生活     【立即下載】  iOS版 / Android版
人氣文章
財經新聞
評論
專題
產品簡介

【etnet Bonus賞你】好好社企 中秋精選月餅禮盒

【etnet Bonus賞你】領展TKO Gateway便攜式香薰機

【etnet Bonus賞你】荃灣千色匯及元朗千色匯 x 韓國紙雕插畫藝術家Soo Min Kim 消暑手搖沙冰杯+簡約家用收納箱